Literature DB >> 24548752

The in vivo and in vitro study of polysaccharides from a two-herb formula on ulcerative colitis and potential mechanism of action.

Linjing Zhao1, Hongbing Wu2, Aihua Zhao3, Huili Lu2, Wei Sun4, Chungwah Ma4, Yiting Yang4, Xue Xin2, Haimiao Zou2, Mingfeng Qiu5, Wei Jia3.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Lycium barbarum and Astragalus membranaceus are two traditional medicinal herbs widely used in China for nourishing Yin and reinforcing Qi. The purpose of the study was to investigate the prophylactic and curative effects of crude polysaccharides (QHPS) extracted from a two-herb formula composed of Lycium barbarum and Astragalus membranaceus at a ratio of 2:3 in colitis rats, and to further elucidate the potential mechanism of action in epithelial cell proliferation in vitro.
MATERIALS AND METHODS: An acetic acid (AA)-induced ulcerative colitis rat model was applied in the study. Two independent protocols were used to assess the prophylactic and curative effects of QHPS, respectively, in which rats were either pre-treated with QHPS (0.18g/kg) for 14 days prior to AA induction, or post-treated with QHPS for 7 days after AA induction. The stool consistency and weight loss were used to evaluate disease activity. The morphological changes in intestinal mucosa at the end of the experiments were observed. The serum levels of endotoxin (EDT), diamine oxidase (DAO) and d-lactate (DLA), important biochemical markers for evaluating intestinal mucosal structure and function, were measured. In the in vitro mechanistic studies, rat intestinal epithelial cells (IEC-6) were used to access for epithelium regeneration.
RESULTS: The intra-colonic instillation of AA induced ulcerative colitis in rat, as indicated by diarrhea, weight loss, and colonic mucosal damage. Both prophylactic and curative treatments effectively reduced the weight loss and diarrhea and attenuated the colonic mucosal damage associated with inducible colitis. The significant increase in serum levels of DAO, DLA and EDT was induced by AA and inhibited by QHPS treatment. Moreover, QHPS could significantly stimulate IEC-6 proliferation in a dose-dependent manner (p<0.05).
CONCLUSION: The present study indicated for the first time that polysaccharides extracted from this two-herb formula can protect against experimental ulcerative colitis, presumably by promoting the recovery of the intestinal barrier.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Astragalus membranaceus; Inflammatory bowel disease; Intestinal barrier; Lycium barbarum; Polysaccharides; Ulcerative colitis

Mesh:

Substances:

Year:  2014        PMID: 24548752     DOI: 10.1016/j.jep.2014.02.008

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  15 in total

1.  Intraperitoneal administration of butyrate prevents the severity of acetic acid colitis in rats.

Authors:  Joshua J Malago; Catherine L Sangu
Journal:  J Zhejiang Univ Sci B       Date:  2015-03       Impact factor: 3.066

Review 2.  An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides.

Authors:  Jiang Cheng; Zhi-Wei Zhou; Hui-Ping Sheng; Lan-Jie He; Xue-Wen Fan; Zhi-Xu He; Tao Sun; Xueji Zhang; Ruan Jin Zhao; Ling Gu; Chuanhai Cao; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

3.  A New Chinese Medicine Intestine Formula Greatly Improves the Effect of Aminosalicylate on Ulcerative Colitis.

Authors:  Baohai Liu; Xuehua Piao; Lianyi Guo; Guijun Wang; Weihua Sun; Leming Gao; Xuefeng Zheng; Yanli Fang
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-20       Impact factor: 2.629

4.  Effects of Jianpi Qingchang decoction on the quality of life of patients with ulcerative colitis: A randomized controlled trial.

Authors:  Yan-Cheng Dai; Lie Zheng; Ya-Li Zhang; Xuan Chen; De-Liang Chen; Zhi-Peng Tang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

Review 5.  New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the "Bacteria-Mucosal Immunity-Inflammation-Diabetes" Axis.

Authors:  Zezheng Gao; Qingwei Li; Xuemin Wu; Xuemin Zhao; Linhua Zhao; Xiaolin Tong
Journal:  J Immunol Res       Date:  2017-10-15       Impact factor: 4.818

6.  Astragaloside II promotes intestinal epithelial repair by enhancing L-arginine uptake and activating the mTOR pathway.

Authors:  Shih-Yu Lee; Wei-Cheng Tsai; Jung-Chun Lin; Blerina Ahmetaj-Shala; Su-Feng Huang; Wen-Liang Chang; Tsu-Chung Chang
Journal:  Sci Rep       Date:  2017-09-26       Impact factor: 4.379

Review 7.  Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines.

Authors:  Peng-De Lu; Yong-Hua Zhao
Journal:  Chin Med       Date:  2020-02-10       Impact factor: 5.455

8.  Traditional Chinese medicine for mild-to-moderate ulcerative colitis: Protocol for a network meta-analysis of randomized controlled trials.

Authors:  Zhaofeng Shen; Qing Zhou; Yingjun Ni; Weiming He; Hong Shen; Lei Zhu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 9.  Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends.

Authors:  Mohammad Al Mijan; Beong Ou Lim
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

10.  The Effect of Encapsulated Powder of Goji Berry (Lycium barbarum) on Growth and Survival of Probiotic Bacteria.

Authors:  Prodromos Skenderidis; Chrysanthi Mitsagga; Dimitrios Lampakis; Konstantinos Petrotos; Ioannis Giavasis
Journal:  Microorganisms       Date:  2019-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.